Effects of mitomycin C and cyclosporine A on experimentally induced glaucoma filtration surgery in rabbit model

被引:0
作者
Kilic, S. [1 ]
Kulualp, K. [2 ]
Muzoglu, O. [3 ]
Ozkaraca, M. [4 ]
机构
[1] Univ Namik Kemal, Dept Surg, Fac Vet Med, Tekirdag, Turkey
[2] Firat Univ, Vocat Sch Hlth Serv, Elazig, Turkey
[3] Directorate Prov Food Agr & Livestock, Elazig, Turkey
[4] Ataturk Univ, Dept Pathol, Fac Vet Med, Erzurum, Turkey
关键词
rabbit; glaucoma filtration surgery; mitomycin C; cyclosporine A; FILTERING SURGERY; COMBINED TRABECULECTOMY; 5-FLUOROURACIL; IMPLANTATION; FIBROSIS;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The present study aims at investigating the effect of topical administration of mitomycin C (MMC) used solely and combined with cyclosporine A (MMC+CsA) on inhibition of the granulation tissue proliferation in experimentally induced glaucoma filtration surgery (GFS) in rabbits. A total of 18 New Zealand breed rabbits, control, MMC, and MMC+CsA groups of 6 subjects in each were used in the study. Clinical signs and complications in GFS region were evaluated using ophthalmoscopy, Schirmer tear test and tonometry 7 times at predetermined intervals between days 0-35. The right eyes of all subjects euthanized at the end of the study were harvested and histopathologically evaluated. According to clinical findings, GFS remained patent in all group subjects during the study except two subjects in the control group. Histopathological examination revealed marked cellular activities around GFS of the control group subjects as compared to the MMC and MMC+CsA groups. In this respect, no difference exists between two experimental groups. It has been observed that the intraocular pressure (IOP) value significantly decreased (P<0.005) in all groups on the day 5, which continued until the day 25 in control and MMC groups, and until the day 20 in the MMC+CsA group. The change in tear production rate showed to be more stable in the MMC+CsA than in the control and MMC groups. MMC and MMC+CsA are determined to have inhibited successfully granulation tissue proliferation around GFS and no marked difference was found between them as compared to the control group. It is suggested that in order to observe difference between these two groups, a more prolonged study is required.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 43 条
[1]   Medical and surgical management of the glaucoma patient [J].
Abrams, KL .
CLINICAL TECHNIQUES IN SMALL ANIMAL PRACTICE, 2001, 16 (01) :71-76
[2]   High intraocular pressure-induced ischemia and reperfusion injury in the optic nerve and retina in rats [J].
Adachi, M ;
Takahashi, K ;
Nishikawa, M ;
Miki, H ;
Uyama, M .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1996, 234 (07) :445-451
[3]  
Barton K, 2001, INVEST OPHTH VIS SCI, V42, P1762
[4]   Modern aqueous shunt implantation: future challenges [J].
Barton, Keith ;
Heuer, Dale K. .
GLAUCOMA: AN OPEN WINDOW TO NEURODEGENERATION AND NEUROPROTECTION, 2008, 173 :263-276
[5]   Topical Silver Nanoparticles Result in Improved Bleb Function by Increasing Filtration and Reducing Fibrosis in a Rabbit Model of Filtration Surgery [J].
Butler, Michelle R. ;
Ponce, Claudia M. Prospero ;
Weinstock, Y. Etan ;
Orengo-Nania, Silvia ;
Chevez-Barrios, Patricia ;
Frankfort, Benjamin J. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (07) :4982-4990
[6]   Morphologic classification of filtering Blebs after glaucoma filtration surgery: The Indiana bleb appearance grading scale [J].
Cantor, LB ;
Mantravadi, A ;
WuDunn, D ;
Swamynathan, K ;
Cortes, A .
JOURNAL OF GLAUCOMA, 2003, 12 (03) :266-271
[7]  
DOYLE JW, 1993, INVEST OPHTH VIS SCI, V34, P3313
[8]  
EREN K., CURRENT EYE RES, V41, P367
[9]   Effects of postoperative cyclosporine ophthalmic emulsion 0.05% (Restasis) following glaucoma surgery [J].
Fakhraie, Ghasem ;
Lopes, Joao F. ;
Spaeth, George L. ;
Almodin, Juliana ;
Ichhpujani, Parul ;
Moster, Marlene R. .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 37 (09) :842-848
[10]   Trabecular meshwork as a new target for the treatment of glaucoma [J].
Ferrer, Elisa .
DRUG NEWS & PERSPECTIVES, 2006, 19 (03) :151-158